Sort   by:  
 Page size 
UnknownMiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway.
Not available
S-EPMC8951736 | biostudies-literature
UnknownNeuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.
Not available
S-EPMC3129808 | biostudies-literature
UnknownNew therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.
Not available
S-EPMC4745691 | biostudies-literature
UnknownCotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling.
Not available
S-EPMC8564655 | biostudies-literature
UnknownNovel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.
Not available
S-EPMC4317336 | biostudies-literature
UnknownGain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes.
Not available
S-EPMC9776607 | biostudies-literature
UnknownComparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).
Not available
S-EPMC11218154 | biostudies-literature
Sort   by:  
 Page size